UnitedHealth Group reported Q3 earnings that exceeded expectations with EPS 13% above consensus, driven by a successful turnaround strategy focusing on shedding unprofitable patient groups and controlling costs. This led to a net margin increase from 2.1% to 3.6%. Management raised the 2026 EPS guidance to at least $20.50, signaling confidence in continued profitability improvements. The outlook remains positive with potential for high-teens total returns over the next 12–24 months as earnings and valuation recover.
UnitedHealth Group's market cap stands at $340.46 billion as of Oct 13, 2026, 20:32 WIB, reflecting its significant scale in the health sector. On Pluang, UNH shares are trading at USD 397.91 with a notable 1-day gain of 5.12%, supported by a dividend yield of 2.45%. Investor interest is strong, with 64% of order activity on Pluang being buys, indicating positive sentiment around the stock's recent earnings surprise.
UnitedHealth shares rose 4% after beating Q3 2026 earnings estimates with adjusted EPS of $4.69 and raising its full-year outlook to at least $20.50. The earnings beat was driven by improved medical care ratio, helped partly by a $610 million reserve...
UnitedHealth Group reported third-quarter earnings that exceeded analyst expectations, with adjusted earnings per share of $4.69 versus the expected $4.14, and revenue of $112.69 billion. The company raised its fiscal 2026 adjusted earnings forecast ...
UnitedHealth Group is set to report earnings on October 13, with options showing implied volatility twice the realized volatility, making options expensive. This creates opportunities for traders to use short premium strategies, such as selling Novem...
Johnson & Johnson and UnitedHealth Group both released their third-quarter 2026 earnings on the same morning, highlighting key trends in drug costs, insurance margins, and sector outlook. Johnson & Johnson showed steady revenue growth with strong per...
UnitedHealth Group is rated a conditional Buy as its profitability improves significantly despite flat revenue and shrinking membership. The company has exited unprofitable business lines, driving margin expansion. Its current valuation is below the ...
